BlackRock Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $406K | Hold |
159,176
| – | – | ﹤0.01% | 3083 |
|
2016
Q3 | $492K | Sell |
159,176
-729
| -0.5% | -$2.25K | ﹤0.01% | 3038 |
|
2016
Q2 | $513K | Buy |
159,905
+10,473
| +7% | +$33.6K | ﹤0.01% | 3045 |
|
2016
Q1 | $463K | Buy |
149,432
+939
| +0.6% | +$2.91K | ﹤0.01% | 2922 |
|
2015
Q4 | $595K | Buy |
148,493
+187
| +0.1% | +$749 | ﹤0.01% | 2923 |
|
2015
Q3 | $679K | Sell |
148,306
-1,007
| -0.7% | -$4.61K | ﹤0.01% | 2877 |
|
2015
Q2 | $775K | Buy |
149,313
+39,890
| +36% | +$207K | ﹤0.01% | 2937 |
|
2015
Q1 | $685K | Buy |
109,423
+482
| +0.4% | +$3.02K | ﹤0.01% | 2783 |
|
2014
Q4 | $685K | Sell |
108,941
-1,058
| -1% | -$6.65K | ﹤0.01% | 2811 |
|
2014
Q3 | $669K | Buy |
109,999
+2,404
| +2% | +$14.6K | ﹤0.01% | 2790 |
|
2014
Q2 | $709K | Buy |
107,595
+23,363
| +28% | +$154K | ﹤0.01% | 2831 |
|
2014
Q1 | $2.01M | Sell |
84,232
-365
| -0.4% | -$8.69K | ﹤0.01% | 2029 |
|
2013
Q4 | $903K | Sell |
84,597
-1,940
| -2% | -$20.7K | ﹤0.01% | 2560 |
|
2013
Q3 | $1.15M | Buy |
86,537
+5,581
| +7% | +$74.4K | ﹤0.01% | 2334 |
|
2013
Q2 | $1.06M | Buy |
+80,956
| New | +$1.06M | ﹤0.01% | 2311 |
|